chr10-101770141-TA-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_033163.5(FGF8):c.*187del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.28 ( 4400 hom., cov: 0)
Exomes 𝑓: 0.26 ( 34 hom. )
Consequence
FGF8
NM_033163.5 3_prime_UTR
NM_033163.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.108
Genes affected
FGF8 (HGNC:3686): (fibroblast growth factor 8) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein is known to be a factor that supports androgen and anchorage independent growth of mammary tumor cells. Overexpression of this gene has been shown to increase tumor growth and angiogensis. The adult expression of this gene is restricted to testes and ovaries. Temporal and spatial pattern of this gene expression suggests its function as an embryonic epithelial factor. Studies of the mouse and chick homologs revealed roles in midbrain and limb development, organogenesis, embryo gastrulation and left-right axis determination. The alternative splicing of this gene results in four transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 10-101770141-TA-T is Benign according to our data. Variant chr10-101770141-TA-T is described in ClinVar as [Benign]. Clinvar id is 1263103.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGF8 | NM_033163.5 | c.*187del | 3_prime_UTR_variant | 6/6 | ENST00000320185.7 | ||
LOC105378457 | XR_007062268.1 | n.138-393del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGF8 | ENST00000320185.7 | c.*187del | 3_prime_UTR_variant | 6/6 | 1 | NM_033163.5 | A2 | ||
FGF8 | ENST00000344255.8 | c.*187del | 3_prime_UTR_variant | 6/6 | 1 | ||||
FGF8 | ENST00000469792.6 | c.*886del | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.276 AC: 33242AN: 120498Hom.: 4402 Cov.: 0
GnomAD3 genomes
AF:
AC:
33242
AN:
120498
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.262 AC: 69632AN: 265486Hom.: 34 Cov.: 0 AF XY: 0.262 AC XY: 35731AN XY: 136342
GnomAD4 exome
AF:
AC:
69632
AN:
265486
Hom.:
Cov.:
0
AF XY:
AC XY:
35731
AN XY:
136342
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.276 AC: 33230AN: 120478Hom.: 4400 Cov.: 0 AF XY: 0.276 AC XY: 15724AN XY: 57040
GnomAD4 genome
AF:
AC:
33230
AN:
120478
Hom.:
Cov.:
0
AF XY:
AC XY:
15724
AN XY:
57040
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 13, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at